Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, novembre 19
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Hims & Hers Health Inc
HIMS
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$17.05
-0.50
-2.85%
In chiusura: Nov 18, 4:00 PM EST
$17.26
-0.29
-1.65%
Pre-mercato: 5:01 AM EST
Get Report
Panoramica
Notizie
Grafici
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Hims & Hers Health Financials
Hims & Hers Health (HIMS) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Hims & Hers Week in Review: Q3 Miss, Weak Q4 Outlook, Huberman Joins Board
Hims & Hers Health Inc. (NYSE: HIMS) had a busy week that included Q3 earnings miss, a board appointment and analyst price target changes.
Dylan Berman
Weight-Loss Reset Dents Hims & Hers Outlook, But Analyst Sees Opportunity
Hims & Hers stock dropped after a Q3 loss and guidance cut, but Needham reaffirmed its Buy rating, seeing the post-earnings pullback as an entry point.
Vandana Singh
These Analysts Revise Their Forecasts On Hims & Hers Health After Q3 Results
Hims & Hers missed Q3 FY26 earnings and revenue estimates, cut guidance, and shares fell 13%; analysts revised price targets.
Avi Kapoor
Hims & Hers Stock Feels a Pinch Tuesday: What's Happening?
Hims & Hers Health Inc. (NYSE: HIMS) shares are trading lower Tuesday after the company reported worse-than-expected Q3 results late Monday.
Dylan Berman
Hims & Hers Stock Slips Further as Q3 Print Disappoints
Here's a detailed look inside the Q3 earnings report from Hims & Hers Health.
Erica Kollmann
PRO
Hims & Hers Health Q3 EPS $(0.14) Misses $0.08 Estimate, Sales $890.373M Miss $892.888M Estimate
Hims & Hers Health (NYSE:HIMS) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $0.08 by 275 percent. This is a 255.56 percent decrease over earnings of $0.09 per share
Benzinga Newsdesk